Seagen(SGEN) - 2020 Q1 - Earnings Call Presentation

FIRST QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATE April 30, 2020 Julie, treated for metastatic breast cancer on a TUKYSA clinical trial Transformative therapies | Targeting cancer 1 Transformative Therapies | Targeting Cancer | Overview and Key Highlights | Clay Siegall, Ph.D., President & CEO | | --- | --- | | Commercial | Chip Romp, EVP, Commercial | | Financial | Todd Simpson, CFO | | Research & Development | Roger Dansey, M.D., CMO | 2 Forward-Looking Statements Certain of the statements made in ...